10x Genomics: Lower Cost Innovation May Drive A Rebound
Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Bank of New York Mellon Corp
Bank of New York Mellon Corp lowered its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 13.5% in the ...
These 10 biotech companies are changing how we discover new drugs and treat complex diseases
The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments ...
10x Genomics, Inc. (NASDAQ:TXG) Receives Consensus Rating of “Hold” from Analysts
Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) have received a consensus rating of “Hold” from the seventeen analysts that are currently covering the company, Ratings reports. One ...